June 21, 2017

Final price in BONESUPPORT™’s initial public offering set at SEK 29 per share – trading on Nasdaq Stockholm commences today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, ...
Read more
June 20, 2017

Onxeo successfully raises €15 Million with US and European investors

Offering upsized in response to investor demand Paris (France), June 20, 2017 – 08:00 am CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the ...
Read more
June 19, 2017

Nordic Nanovector to present to investors at the Citi European Healthcare Conference

Oslo, Norway, 19 June 2017 Nordic Nanovector ASA (OSE: NANO) announces that Nordic Nanovector will attend the Citi European Healthcare Conference on 20-21 June in London, UK...
Read more
June 19, 2017

Onxeo launches a capital increase by means of an accelerated book-build offering

Paris (France), June 19, 2017 – 05:45 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology compan...
Read more
June 14, 2017

Tisbury Pharmaceuticals Launches with a USD 32 Million Series A Financing to Develop First-in-class Therapeutics for Glaucoma

Investment proceeds to be used to develop Tisbury's proprietary glaucoma compound, R-801 Boston, Massachusetts (PRWEB) June 14, 2017 Tisbury Pharmaceuticals, Inc., a pha...
Read more
June 14, 2017

Single dose Betalutin® continues to show promising efficacy and safety in recurrent indolent NHL patients

Updated results reported at the International Conference on Malignant Lymphoma (ICML) Oslo, Norway, 14 June 2017 Nordic Nanovector ASA (OSE: NANO) announces that updated re...
Read more
June 14, 2017

GenSight Biologics reports long-term positive safety and visual acuity results at Week 96 in Phase I/II Study of GS010 for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Sustained clinically significant improvement of visual acuity in LHON patients with less than 2 years of visual loss Confirmation of the long-term safety profile of GS010 P...
Read more
June 13, 2017

Strongbridge Biopharma plc to Participate in the JMP Securities Life Science Conference

DUBLIN, Ireland and TREVOSE, Pa., June 13, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global commercial-stage biopharmaceutical company focused on the dev...
Read more
June 12, 2017

CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors

June 12, 2017 08:00 AM Eastern Daylight Time PHILADELPHIA--(BUSINESS WIRE)--CARMA Therapeutics Inc., a biotechnology company developing cellular immunotherapies, co-founded by...
Read more
June 11, 2017

BONESUPPORT™ announces initial public offering on Nasdaq Stockholm and a related prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, ...
Read more